Royalty Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Royalty Pharma plc (RPRX) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.620.930.501.712.191.01
Short-Term Investments0.020.840.020.031.261.05
Cash & Short-Term Investments0.641.770.501.742.192.06
Accounts Receivable0.000.030.760.730.630.63
Inventory0.000.000.000.000.000.00
Other Current Assets-0.020.000.000.090.010.01
Total Current Assets0.621.801.272.552.882.70
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.00
Long-Term Investments0.1716.391.010.740.440.92
Goodwill0.920.000.000.000.000.00
Intangible Assets0.0015.130.000.010.010.03
Other Non-Current Assets15.97-15.090.020.020.000.01
Total Non-Current Assets17.0616.4215.1214.2614.6413.36
Total Assets19.6218.2216.3816.8117.5216.02
Current Liabilities
Accounts Payable0.000.010.070.010.170.01
Short-Term Debt0.381.000.001.000.000.00
Current Portion of Long-Term Debt0.001.000.001.000.000.00
Accrued Liabilities0.000.100.050.050.060.06
Other Current Liabilities0.260.240.090.110.000.24
Total Current Liabilities0.641.250.161.170.170.31
Non-Current Liabilities
Long-Term Debt8.576.616.146.127.105.82
Other Non-Current Liabilities0.700.010.000.000.000.02
Total Non-Current Liabilities9.276.636.146.127.105.82
Total Liabilities9.917.886.307.297.276.12
Stockholders' Equity
Common Stock0.000.000.000.000.000.00
Retained Earnings2.362.852.521.962.261.92
Accumulated Other Comprehensive Income0.000.000.000.000.020.03
Treasury Stock0.000.000.000.000.000.00
Additional Paid-in Capital7.364.104.013.673.512.87
Minority Interest0.073.403.563.904.475.08
Shares Outstanding0.000.450.450.440.430.00
Total Stockholders' Equity9.716.9510.089.5310.259.90
Total Liabilities & Equity19.6218.2216.3816.8117.5216.02